The war is changing the situation on the drug market: there is a certain shortage with imported medicines, and many of the Western pharmaceutical companies are still operating in the…
Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Roughly a year after disclosing plans to…